Health Sciences Authority

HSA’s Chemical Metrology Division (CMD) is excited to share our latest publication on Certified Reference Material for Inorganic Contaminants in Insect Protein. We are honoured to be invited to contribute a research paper to Analytical and Bioanalytical Chemistry’s special collection on "Reference Materials in Analytical Chemistry." This special collection features current research activities in the area of reference materials that underpin reliability of measurements as well as critical reviews on recent developments and future trends in this area.   As the demand for sustainable protein sources grows, ensuring the safety and quality of insect-based proteins is more important than ever. Our study details the development of a cricket powder certified reference material with intrinsically present arsenic, cadmium, chromium, mercury, lead, arsenic species, and selenium, providing a metrologically traceable solution for accurately assessing these contaminants in insect protein. This work is a significant step toward advancing food safety and regulatory compliance in the emerging insect protein industry.   A special thanks to our collaborator, the National Research Council Canada / Conseil national de recherches Canada, for their invaluable contribution to this research!   Congratulations to the team: Dr Fransiska Dewi, Deborah Sim, Dr Sin Yee Ng, Leung Ho Wah, Dr Richard Shin, Dr Tang Lin Teo, and our esteemed collaborator and co-author Dr Zoltan Mester.   Find the manuscript here: https://lnkd.in/g3vM-Kq4   #FoodSafety #CertifiedReferenceMaterial #InsectProtein #Metrology #Sustainability #AnalyticalScience

From 8 to 9 March 2025, about 40 HSAians laced up their running shoes 👟👟 to join the Ministry of Health (Singapore) (MOH) family in the Relay for Life 100KM challenge. Paving the way, HSA CEO Adj Prof (Dr) Raymond Chua, together with several Directors, ran alongside to show their support for staff and for this meaningful event.   Collaborating closely with MOH colleagues, our team’s unstoppable spirit, drove us to exceed expectations, completing the challenge ahead of schedule and surpassing both distance and time targets.  We are thrilled that the Healthcare Family Trail Trekkers Team 2 emerged as 1st runner-up at the overnight relay. Together with another team, they clocked a total of 365.4 km which doubled the distance covered last year! Through this collective effort, together we proudly 𝗿𝗮𝗶𝘀𝗲𝗱 𝗼𝘃𝗲𝗿 $𝟮𝟳,𝟬𝟬𝟬—a testament to our dedication, teamwork, and commitment to supporting this cause! 🙌   Beyond speed and endurance, this run carried a deeper purpose for us. Every step we took was a reminder of why we were there: 🛡️ To celebrate our cancer warriors - those who fight with resilience every day. 🕯️ To remember loved ones lost - honouring their strength and legacy. 🤝 To fight back together - because no one should battle cancer alone.   At HSA, we are committed to advancing health sciences and supporting the well-being of our community. Through this run, we reaffirm our dedication to making a difference—both in our work and in the lives of those around us.   A heartfelt thank you to all runners, supporters, and the big healthcare family (Agency for Integrated Care (Singapore), ALPS Pte. Ltd., Health Promotion Board, Ministry of Health (Singapore), MOH Holdings (Singapore), MOH Office for Healthcare Transformation (MOHT) & Synapxe) for 𝘳𝘶𝘯𝘯𝘪𝘯𝘨 this meaningful journey with us and making it possible! 💙 ➡️ If you would like to show your support to our team, click here to donate! https://lnkd.in/gqnsXwTK #RelayForLife2025 #RelayForLifeSG #HealthSciencesAuthority #HSA #LifeinHSA

Dr Fransiska Dewi, a Senior Analytical Scientist from HSA’s Chemical Metrology Division had the privilege of participating in the 1st Drafting Workshop of the ASEAN Plan of Action for Science, Technology, and Innovation (APASTI) 2026–2035 held in Jakarta on 5 March 2025. At the workshop, as the Chair of the ASEAN Reference Material Network, she presented the network's vision, goals, and objectives for the future of APASTI, along with key stakeholders to consider in its development.   The workshop brought together representatives from ASEAN Member States, stakeholders, and experts to chart a roadmap for advancing science, technology, and innovation (STI) across the region. It aimed to develop a strategic framework that enhances ASEAN’s STI ecosystem, fosters cross-border collaboration, and drives inclusive and sustainable development. Discussions focused on key priorities, stakeholders, goals and action plans for APASTI 2026 - 2035.   A sincere thank you to the organisers from Aus4ASEAN, ASEAN Secretariat, and the dedicated consultants from Ernst & Young for making this workshop a success. Their efforts in fostering regional cooperation played a crucial role in shaping ASEAN’s future in science, technology, and innovation.   Following the workshop, Fransiska also visited our counterpart metrology institute in Indonesia, the National Standardization Agency of Indonesia (BSN). This visit provided an opportunity to explore areas of collaboration and strengthen ties between our institutes to support regional metrology infrastructure. A heartfelt thank you to BSN for the warm hospitality and engaging discussions.   Looking forward to continued collaboration towards a stronger, more innovative and inclusive ASEAN!   #ASEAN #ScienceInnovation #RegionalCollaboration #APASTI

This International Women's Day, we highlight Grace Chan, Director of Finance & Procurement. Grace's approach to life, like her daily coffee, is energising — showing how consistent habits can fuel significant achievements over time. Her leadership in financial management and procurement has optimised resources and driven efficiency. As we celebrate contributions by women worldwide, let Grace's purposeful mornings inspire us to find our own sources of strength and motivation. What daily habit motivates you? Tell us in the comments! #InternationalWomensDay

On this International Women's Day, we showcase inspirational female leaders at HSA. Wong Woei Jiuang, Assistant Group Director of the Medical Devices Cluster, Health Products Regulation Group, leads her team to upkeep standards of safety, quality and performance whilst facilitating innovation in medical device development. She guides her co-workers in their work and helps them to grow and develop as individuals even as they handle the many challenges in the fast-changing medical technology landscape. Swipe to see how Woei Jiuang leads and inspires her team. Which leadership qualities do you admire most? Share your thoughts below. #InternationalWomensDay

This International Women's Day, we honour the outstanding accomplishments and contributions of women. We're proud to recognise Sally Lam, Division Director of Blood Supply Management at HSA. Her unwavering commitment to excellence ensures Singapore has a safe and sustainable blood supply. Sally's empowering leadership and drive for innovation inspire her team to excel, contributing significantly to our nation's healthcare. What leadership qualities do you find most inspiring in women like Sally? Share your thoughts in the comments. #InternationalWomensDay

In celebration of International Women's Day, we are spotlighting four dynamic females at HSA who helped shape our organisation with their vision, expertise and resilience. They lead with exceptional leadership, fostering innovation and driving positive change. Their commitment to excellence, and their ability to influence and mentor others set inspiring examples for all. We honour their contributions and hope that they inspire all future generations of female and male leaders. Today, we start off the feature with Dr Tang Lin Teo, Division Director of the Chemical Metrology Division. Together with her team, Dr Teo has contributed to the continuous growth of our nation's chemical metrology capabilities in food, healthcare, medical science, health products and others. As the first Singaporean Metrologist to chair the largest Technical Committee within the Asia Pacific Metrology Programme, her appointment reflects the region's confidence in her ability to advance chemical metrology capabilities. Her work ensures precise chemical measurements that impact our daily lives in countless ways: food safety, clinical diagnostics, and others. All these efforts have enabled enhanced quality control, informed decision-making, and reliable research findings, ultimately contributing to public health and safety. With Dr Teo and her team’s commitment to scientific excellence, HSA has forged strong collaborative international partnerships, raising the impact of chemical metrology domestically and beyond our shores.    Her commitment to precision and excellence in the lab mirrors her approach in her daily life – one which embodies efficiency and accuracy.  Watch the clip to see her daily reminder at work.    What's your daily reminder or inspiration? Share with us in the comments! #InternationalWomensDay 

Introducing the First Certified Reference Material (CRM) for Human Urine Albumin Approved by the Joint Committee for Traceability in Laboratory Medicine! HSA is proud to be the first in the world to roll out our CRM HRM-3004A for human urine albumin measured using our reference measurement procedure: Designed to support the calibration and validation of urine albumin measurements, our CRM ensures precision, reliability, and compliance with the highest metrological standards. Additionally, our CRM has been rigorously validated for commutability, ensuring it performs accurately across a broad range of IVD medical devices. Why is urine albumin measurement important? Albumin levels in urine are a key biomarker for early detection of kidney disease, particularly in individuals with diabetes or hypertension. Accurate urine albumin testing enables early intervention, helping to prevent disease progression and improve patient outcomes. Our CRM ensures: ✅ Traceability to the International System of Units for enhanced measurement confidence ✅ High accuracy and consistency to support clinical and research applications Developed by HSA’s Chemical Metrology Laboratory (CML) and acknowledged by the Joint Committee for Traceability in Laboratory Medicine (JCTLM), our CRM provides the precision and reliability IVD manufacturers and clinical laboratories need for quality-assured urine albumin measurement. The CRM was also used in studying the extent of equivalence of results for urine albumin determined by three mass spectrometric reference measurement procedures from HSA, the National Institute of Science and Technology and the University of Minnesota. Read our paper on this here: https://lnkd.in/d4g75Dyg, as well as our paper on the reference method procedure: https://lnkd.in/dmutzBvD Be at the forefront of diagnostic excellence—contact us at hsa_cmleqa@hsa.gov.sg today to learn more! #ClinicalDiagnostics #LaboratoryAccuracy #CertifiedReferenceMaterial #UrineAlbumin #NMI #PrecisionMatters #KidneyHealth

We are proud to announce that our CEO, Adj Prof (Dr) Raymond Chua, has been promoted to Adjunct Professor at the NUS Saw Swee Hock School of Public Health! This appointment is a testament to his deep experience and knowledge, which will continue to enrich the healthcare community. HSA will forge ahead boldly under his inspiring leadership as he guides our organisation towards our strategic vision. Congratulations, Raymond, on this well-deserved achievement!

👉𝗛𝗦𝗔-𝗦𝗖𝗥𝗜 𝗣𝘂𝗯𝗹𝗶𝗰 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝘁𝗵𝗲 𝗳𝗶𝗻𝗮𝗹 𝗜𝗖𝗛 𝗘𝟲 (𝗥𝟯) 𝗚𝗼𝗼𝗱 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲 𝗼𝗻 𝟮𝟴 𝗙𝗲𝗯 𝟮𝟬𝟮𝟱 The Health Sciences Authority and the Singapore Clinical Research Institute (SCRI) co-organised a public webinar today on insights to the Principles and Annex 1 document of the final ICH E6 (R3) GCP Guideline. We were honoured to have our CEO, @Adj A/Prof (Dr) Raymond Chua, deliver the opening address all the way from Amsterdam, despite having to wake up earlier to log in at 0530 hrs! 😅 CEO shared about the Research Innovation and Enterprise (RIE) 2025 plan, which represents our commitment to advancing the nation's research and innovation capabilities, and strengthen Singapore's position as a global hub for scientific discovery and technological innovation. We were also honoured to have @Adj A/Prof (Dr) Danny Soon (CEO, CRIS and Executive Director, SCRI) to deliver the opening address. A/Prof Soon shared SCRI's role in ensuring that our strategies remain effective and responsive to the evolving clinical trial ecosystem. Having been a Topic Lead representing HSA at the ICH E6 (R3) Expert Working Group since its inception in 2019, it was exciting to provide an overview about the major changes to the Principles and Annex 1 document of the ICH E6 GCP guideline, and provide practical examples to enable our stakeholders to have a better understanding of the guideline.😊 It has been an arduous journey for the ICH E6 (R3) EWG, with weekly teleconferences 2-3 times a week, 6-monthly face-to-face meetings and a lot of personal time in between to revise the guideline. Immensely grateful to HSA for giving me this golden opportunity to represent HSA on the global front! Over 1300 participants from 48 countries attended the webinar. 🤩We received about 100 questions during the Q&A session. The webinar was a resounding success! Nothing would have been possible without invaluable support from HSA and SCRI colleagues involved in co-organising the webinar!🙌 Please note that the slide deck and webinar recording will be uploaded in the HSA website soon. 𝗧𝗵𝗲𝗿𝗲 𝗶𝘀 𝘀𝘁𝗶𝗹𝗹 𝗮 𝗹𝗼𝘁 𝗼𝗳 𝘄𝗼𝗿𝗸 𝘁𝗼 𝗯𝗲 𝗱𝗼𝗻𝗲 𝗯𝗲𝗳𝗼𝗿𝗲 𝘁𝗵𝗲 𝗶𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝘁𝗶𝗺𝗲𝗹𝗶𝗻𝗲 𝗼𝗳 𝟭 𝗝𝗮𝗻 𝟮𝟬𝟮𝟲 𝗳𝗼𝗿 𝗦𝗶𝗻𝗴𝗮𝗽𝗼𝗿𝗲: ✅Read through the guideline in its entirety ✅Perform a detailed gap analysis of the guideline  ✅Revise your Quality Management System to ensure compliance ✅Seek clarification about the guideline, where required ✅Adopt a proportionate, risk-based approach to training 📸Singapore Clinical Research Institute (SCRI) Health Sciences Authority #HSA